Zhihong Yang Selected Research

Hypoxia (Hypoxemia)

1/2024	Aging Increases Hypoxia-Induced Endothelial Permeability and Blood-Brain Barrier Dysfunction by Upregulating Arginase-II.
2/2023	Paracrine Effects of Renal Proximal Tubular Epithelial Cells on Podocyte Injury under Hypoxic Conditions Are Mediated by Arginase-II and TGF-β1.
1/2022	Role of Arginase-II in Podocyte Injury under Hypoxic Conditions.
1/2021	Hypoxia Induces Renal Epithelial Injury and Activates Fibrotic Signaling Through Up-Regulation of Arginase-II.
1/2019	Hypoxia Enhances Endothelial Intercellular Adhesion Molecule 1 Protein Level Through Upregulation of Arginase Type II and Mitochondrial Oxidative Stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhihong Yang Research Topics

Disease

40	Neoplasms (Cancer) 04/2024 - 02/2010
23	Inflammation (Inflammations) 03/2024 - 03/2009
11	Obesity 11/2022 - 11/2005
11	Atherosclerosis 01/2019 - 02/2003
10	Carcinogenesis 12/2019 - 04/2010
9	Hepatocellular Carcinoma (Hepatoma) 08/2023 - 10/2011
8	Body Weight (Weight, Body) 11/2022 - 01/2008
7	Liver Diseases (Liver Disease) 01/2024 - 08/2017
7	Liver Cirrhosis (Hepatic Cirrhosis) 11/2023 - 01/2019
7	Fibrosis (Cirrhosis) 11/2023 - 12/2017
7	Insulin Resistance 11/2022 - 01/2008
6	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2007
5	Hypoxia (Hypoxemia) 01/2024 - 01/2019
5	Retinopathy of Prematurity (Retrolental Fibroplasia) 11/2018 - 09/2013
4	Multiple Myeloma 04/2024 - 01/2019
4	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2015
4	Colorectal Neoplasms (Colorectal Cancer) 09/2020 - 10/2011
4	Colonic Neoplasms (Colon Cancer) 01/2019 - 02/2010
4	Liver Neoplasms (Liver Cancer) 10/2017 - 04/2012
4	Lung Neoplasms (Lung Cancer) 08/2017 - 03/2011
4	Acute Coronary Syndrome 01/2017 - 04/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 02/2016 - 01/2014
3	Ischemic Stroke 01/2024 - 06/2019
3	Albuminuria 07/2023 - 01/2018
3	Cholestasis 01/2021 - 01/2017
3	Non-alcoholic Fatty Liver Disease 12/2017 - 02/2016
3	Thrombosis (Thrombus) 01/2017 - 07/2005
3	Glucose Intolerance 01/2017 - 01/2008
3	Type 2 Diabetes Mellitus (MODY) 06/2013 - 06/2010
2	Reperfusion Injury 01/2024 - 07/2009
2	Brain Ischemia (Cerebral Ischemia) 01/2024 - 06/2019
2	Disease Progression 03/2023 - 01/2022
2	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2022 - 08/2017
2	Alcoholic Hepatitis 01/2022 - 01/2022
2	Hepatitis 11/2021 - 10/2020
2	Ischemia 01/2021 - 07/2009
2	Sclerosing Cholangitis 11/2020 - 10/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 06/2019 - 07/2013
2	Hypertrophy 01/2018 - 02/2003
2	Fatty Liver 01/2018 - 03/2015

Drug/Important Bio-Agent (IBA)

22	ArginaseIBA 01/2024 - 12/2004
14	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2003
9	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 01/2010
8	EnzymesIBA 04/2023 - 03/2009
8	MicroRNAs (MicroRNA)IBA 01/2022 - 03/2015
7	Arginine (L-Arginine)FDA Link 01/2021 - 07/2013
6	Messenger RNA (mRNA)IBA 11/2020 - 09/2016
6	Insulin (Novolin)FDA Link 09/2019 - 01/2008
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 01/2012
5	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2017
5	7- ethyl- 7- hydroxy- 10H- 1,3- Dioxolo(4,5- g)pyrano(3',4':6,7)indolizino(1,2- b)quinoline- 8,11(7H,12H)- dioneIBA 09/2020 - 01/2017
5	Transcription Factors (Transcription Factor)IBA 05/2019 - 02/2007
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2018 - 09/2013
5	Thromboplastin (Tissue Factor)IBA 01/2017 - 04/2004
5	Tocopherols (Tocopherol)IBA 09/2013 - 04/2010
5	Vitamin E FDA LinkGeneric 06/2013 - 04/2010
4	idecabtagene vicleucelIBA 04/2024 - 01/2019
4	Oxygen (Dioxygen)IBA 01/2024 - 03/2011
4	Long Noncoding RNAIBA 01/2021 - 01/2017
4	Small Interfering RNA (siRNA)IBA 11/2020 - 09/2013
4	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2019 - 03/2009
4	Nitric Oxide Synthase (NO Synthase)IBA 01/2018 - 03/2005
4	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2016 - 01/2012
4	Retinaldehyde (Retinal)IBA 04/2014 - 09/2013
4	Apolipoproteins E (ApoE)IBA 01/2014 - 03/2005
4	PolyphenolsIBA 06/2013 - 03/2009
3	Sirolimus (Rapamycin)FDA Link 04/2023 - 07/2005
3	AMP-Activated Protein KinasesIBA 01/2022 - 01/2014
3	Ethanol (Ethyl Alcohol)IBA 01/2022 - 05/2015
3	ChemokinesIBA 03/2021 - 01/2020
3	CatalaseIBA 12/2020 - 01/2018
3	MorpholinosIBA 11/2020 - 10/2019
3	VimentinIBA 10/2019 - 04/2015
3	Superoxides (Superoxide)IBA 01/2019 - 03/2009
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2019 - 03/2009
3	LipidsIBA 01/2019 - 03/2015
3	Blood Glucose (Blood Sugar)IBA 01/2018 - 01/2010
3	AntioxidantsIBA 01/2018 - 03/2009
3	Cisplatin (Platino)FDA LinkGeneric 06/2016 - 04/2010
3	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2014 - 03/2009
3	Estrogen ReceptorsIBA 08/2013 - 02/2007
3	ApolipoproteinsIBA 07/2013 - 03/2005
3	TeaIBA 06/2013 - 05/2010
3	Atorvastatin (Lipitor)FDA Link 08/2012 - 02/2010
2	Neurotransmitter Agents (Neurotransmitter)IBA 03/2024 - 05/2023
2	ResveratrolIBA 01/2024 - 03/2009
2	pterostilbeneIBA 01/2024 - 11/2020
2	HMGB2 ProteinIBA 11/2023 - 10/2017
2	physalin AIBA 08/2023 - 07/2023
2	B-Cell Maturation AntigenIBA 03/2023 - 01/2019
2	Chimeric Antigen ReceptorsIBA 03/2023 - 01/2019
2	CytokinesIBA 01/2023 - 03/2021
2	Neutralizing AntibodiesIBA 11/2022 - 09/2013
2	Monoclonal AntibodiesIBA 11/2022 - 06/2018
2	RotenoneIBA 01/2021 - 01/2019
2	Superoxide DismutaseIBA 12/2020 - 01/2010
2	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 11/2020 - 04/2010
2	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 01/2018 - 01/2017

Therapy/Procedure

8	Therapeutics 03/2023 - 10/2011
2	Photothermal Therapy 12/2018 - 06/2018